Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development

Differences in sex development (DSD) are often correlated with a genetic etiology. This study aimed to assess the etiology of DSD patients following a protocol of genetic testing. Materials and methods. This study prospectively investigated a total of 267 patients with DSD who presented to Clinical Emergency Hospital for Children Cluj-Napoca between January 2012 and December 2019. Each patient was clinically, biochemically, and morphologically evaluated. As a first intervention, the genetic test included karyotype + SRY testing. A high value of 17-hydroxyprogesterone was found in 39 patients, in whom strip assay analysis of the CYP21A2 gene was subsequently performed. A total of 35 patients were evaluated by chromosomal microarray technique, and 22 patients were evaluated by the NGS of a gene panel. Results. The karyotype analysis established the diagnosis in 15% of the patients, most of whom presented with sex chromosome abnormalities. Genetic testing of CYP21A2 established a confirmation of the diagnosis in 44% of patients tested. SNP array analysis was particularly useful in patients with syndromic DSD; 20% of patients tested presented with pathogenic CNVs or uniparental disomy. Gene panel sequencing established the diagnosis in 11 of the 22 tested patients (50%), and the androgen receptor gene was most often involved in these patients. The genes that presented as pathogenic or likely pathogenic variants or variants of uncertain significance were RSPO1, FGFR1, WT1, CHD7, AR, NIPBL, AMHR2, AR, EMX2, CYP17A1, NR0B1, GNRHR, GATA4, and ATM genes. Conclusion. An evaluation following a genetic testing protocol that included karyotype and SRY gene testing, CYP21A2 analysis, chromosomal analysis by microarray, and high-throughput sequencing were useful in establishing the diagnosis, with a spectrum of diagnostic yield depending on the technique (between 15 and 50%). Additionally, new genetic variants not previously described in DSD were observed.

[1]  A. Sinclair,et al.  Analysis of the androgen receptor (AR) gene in a cohort of Indonesian undermasculinized 46, XY DSD patients , 2021, Egyptian Journal of Medical Human Genetics.

[2]  A. Sinclair,et al.  Analysis of variants in GATA4 and FOG2/ZFPM2 demonstrates benign contribution to 46,XY disorders of sex development , 2020, Molecular genetics & genomic medicine.

[3]  F. Suárez-Obando,et al.  Disorders of sex development: Genetic characterization of a patient cohort , 2019, Molecular medicine reports.

[4]  G. Conway,et al.  Next-Generation Sequencing Reveals Novel Genetic Variants (SRY, DMRT1, NR5A1, DHH, DHX37) in Adults With 46,XY DSD , 2019, Journal of the Endocrine Society.

[5]  Martine Cools,et al.  Caring for individuals with a difference of sex development (DSD): a Consensus Statement , 2018, Nature Reviews Endocrinology.

[6]  B. Chávez,et al.  Mutational analysis of the androgen receptor (NR3C4) gene in patients with 46,XY DSD. , 2018, Gene.

[7]  J. Papp,et al.  Genetics of Disorders of Sex Development: The DSD-TRN Experience. , 2017, Endocrinology and metabolism clinics of North America.

[8]  Xuefan Gu,et al.  Diagnostic Application of Targeted Next-Generation Sequencing of 80 Genes Associated with Disorders of Sexual Development , 2017, Scientific Reports.

[9]  H. Yoo,et al.  Diagnostic yield of targeted gene panel sequencing to identify the genetic etiology of disorders of sex development , 2017, Molecular and Cellular Endocrinology.

[10]  John Hutson,et al.  Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort , 2016, Genome Biology.

[11]  A. Springer,et al.  Worldwide prevalence of hypospadias. , 2016, Journal of pediatric urology.

[12]  Asan,et al.  Targeted next-generation sequencing identification of mutations in patients with disorders of sex development , 2016, BMC Medical Genetics.

[13]  Eric Vilain,et al.  Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care , 2016, Hormone Research in Paediatrics.

[14]  S. Ahmed,et al.  UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development ( Revised 2015 ) , 2015 .

[15]  H. Karabulut,et al.  Investigation of androgen receptor gene mutations in a series of 21 patients with 46,XY disorders of sex development , 2015, Journal of pediatric endocrinology & metabolism : JPEM.

[16]  J. Achermann,et al.  Disorders of sex development: effect of molecular diagnostics , 2015, Nature Reviews Endocrinology.

[17]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[18]  S. Nelson,et al.  Exome sequencing for the diagnosis of 46,XY disorders of sex development. , 2015, The Journal of clinical endocrinology and metabolism.

[19]  P. Lichtenstein,et al.  Population based nationwide study of hypospadias in Sweden, 1973 to 2009: incidence and risk factors. , 2014, The Journal of urology.

[20]  Xijin Xu,et al.  Anogenital distance and its application in environmental health research , 2014, Environmental Science and Pollution Research.

[21]  D. Milewicz,et al.  Single-nucleotide polymorphism array genotyping is equivalent to metaphase cytogenetics for diagnosis of Turner syndrome , 2013, Genetics in Medicine.

[22]  Hutton M. Kearney,et al.  ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013 , 2013, Genetics in Medicine.

[23]  S. Mansour,et al.  Does MRI add to ultrasound in the assessment of disorders of sex development? , 2012, European journal of radiology.

[24]  A. Sinclair,et al.  Copy Number Variation in Patients with Disorders of Sex Development Due to 46,XY Gonadal Dysgenesis , 2011, PloS one.

[25]  C. Bouvattier CHAPTER 35 – DISORDERS OF SEX DEVELOPMENT: ENDOCRINE ASPECTS , 2010 .

[26]  Riaz Ahmad,et al.  Association of Mayer-Rokitansky-Küster-Hauser syndrome with Thrombocytopenia Absent Radii syndrome: a rare presentation. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[27]  U. Thyen,et al.  Epidemiology and Initial Management of Ambiguous Genitalia at Birth in Germany , 2006, Hormone Research in Paediatrics.

[28]  P. A. Lee,et al.  Consensus statement on management of intersex disorders , 2006, Archives of Disease in Childhood.